Who invested in Aer Therapeutics?
Aer Therapeutics's investors include Canaan, OrbiMed and Hatteras Venture Partners.
United States · Venture startup
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 2 months ago
Funding summaryUpdated 26 Oct 2026
$8.0Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $3.0M sold, first sale Aug 2026
Source recordedSEC filing: $5.0M sold, first sale Jan 2025
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Aer Therapeutics's investors include Canaan, OrbiMed and Hatteras Venture Partners.
Aer Therapeutics has raised $8.0M across 2 rounds since 2025.
Aer Therapeutics's most recent round, $3.0M, was in Aug 2026.
Aer Therapeutics's largest round on record is $5.0M (Venture), in Feb 2025.
Aer Therapeutics's first round on record, in Feb 2025, was backed by Canaan, OrbiMed and Hatteras Venture Partners.
Aer Therapeutics's latest named round is a Venture, in Feb 2025.
Aer Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.